New biomarkers in T-cell lymphomas.

Abstract : Peripheral T-cell lymphomas (PTCLs) are heterogeneous and uncommon malignancies characterized by an aggressive clinical course and a mostly poor outcome with current treatment strategies. The recent genome-wide molecular characterization of several entities has provided novel insights into their pathobiology and led to the identification of new biomarkers with diagnostic, prognostic or therapeutic implications for PTCL patients. Cell lineage and differentiation antigens (markers of γδ or NK lineage, of cytotoxicity, of follicular helper T cells) reflect the tumour's biological behaviour, and their detection in tissue samples may refine the diagnostic and prognostic stratification of the patients. Previously unrecognized gene rearrangements are being discovered (ITK-SYK translocation, IRF4/MUM1 and DUSP22 rearrangements), and may serve as diagnostic genetic markers. Deregulated molecules within oncogenic pathways (NF-κB, Syk, PDGFRα) and immunoreactive cell-surface antigens (CD30, CD52) have been brought to the fore as potential targets for guiding the development of novel therapies.
Type de document :
Article dans une revue
Best Practice and Research: Clinical Haematology, Elsevier, 2012, 25 (1), pp.13-28. 〈10.1016/j.beha.2012.01.004〉
Liste complète des métadonnées

Littérature citée [107 références]  Voir  Masquer  Télécharger
Contributeur : Georges Guellaen <>
Soumis le : mercredi 2 mai 2012 - 08:58:28
Dernière modification le : mercredi 29 novembre 2017 - 10:29:34
Document(s) archivé(s) le : jeudi 15 décembre 2016 - 03:45:22


Fichiers produits par l'(les) auteur(s)




Bettina Bisig, Philippe Gaulard, Laurence De Leval. New biomarkers in T-cell lymphomas.. Best Practice and Research: Clinical Haematology, Elsevier, 2012, 25 (1), pp.13-28. 〈10.1016/j.beha.2012.01.004〉. 〈inserm-00693167〉



Consultations de la notice


Téléchargements de fichiers